title: [Management of subclinical hyperthyroidism].
abstract: Management of subclinical hyperthyroidism (low TSH and normal thyroid hormones) is controversial. Knowledge of its causes, clinical context and associated morbidity is required. It is recommended to follow six steps in exploration and treatment: 1) confirmation, 2) estimation of severity, 3) cause assessment, 4) study of complications, 5) balance whether treatment is needed and 6) if necessary, choice of the most appropriate form. In its management, the same treatments are used as in overt hyperthyroidism.
authors.affiliation: Departamento de Endocrinologia y Nutrición, Clínica Universitaria, Facultad de Medicina, Universidad de Navarra, España. jcgalofre@unav.es
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: Galofré
mesh_terms: D000236:Adenoma / Q000150:complications; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000465:Algorithms; D019468:Disease Management; D006044:Goiter, Nodular / Q000150:complications; D006801:Humans; D006980:Hyperthyroidism / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008875:Middle Aged; D013963:Thyroid Hormones / Q000097:blood; D013964:Thyroid Neoplasms / Q000150:complications; D013965:Thyroidectomy / Q000379:methods; D013966:Thyroiditis / Q000150:complications; D013972:Thyrotropin / Q000097:blood / Q000172:deficiency
chemical_list: D000319:Adrenergic beta-Antagonists; D007457:Iodine Radioisotopes; D013963:Thyroid Hormones; D013972:Thyrotropin